These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15503372)

  • 1. MultiHance in multiple sclerosis: update of a study in progress.
    Tartaro A
    Eur Radiol; 2004 Jun; 14 Suppl 7():O16-9; discussion O20-1. PubMed ID: 15503372
    [No Abstract]   [Full Text] [Related]  

  • 2. MultiHance in brain tumor imaging.
    Jansen O
    Eur Radiol; 2004 Jun; 14 Suppl 7():O5-9; discussion O20-1. PubMed ID: 15503370
    [No Abstract]   [Full Text] [Related]  

  • 3. MultiHance in cardiac magnetic resonance imaging.
    Schneider G; Saedi D; Massmann A; Fries P; Boehm M; Kramann B; Winter H
    Eur Radiol; 2004 Jun; 14 Suppl 7():O71-9; discussion O84-5. PubMed ID: 15503380
    [No Abstract]   [Full Text] [Related]  

  • 4. MultiHance for dynamic MR imaging of the breast.
    Sardanelli F
    Eur Radiol; 2004 Jun; 14 Suppl 7():O65-70; discussion O84-5. PubMed ID: 15503379
    [No Abstract]   [Full Text] [Related]  

  • 5. MultiHance and state-of-the-art contrast-enhanced MRI.
    Spinazzi A
    Eur Radiol; 2004 Jun; 14 Suppl 7():O87-8. PubMed ID: 15503382
    [No Abstract]   [Full Text] [Related]  

  • 6. MultiHance in brain perfusion.
    Essig M
    Eur Radiol; 2004 Jun; 14 Suppl 7():O10-5; discussion O20-1. PubMed ID: 15503371
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancing our understanding of multiple sclerosis: tracking contrast-enhancing plaques with MR imaging.
    Maravilla KR
    AJNR Am J Neuroradiol; 2001 Apr; 22(4):601-3. PubMed ID: 11290465
    [No Abstract]   [Full Text] [Related]  

  • 8. MultiHance-enhanced MRI in the characterisation of focal liver lesions.
    Leen E
    Eur Radiol; 2004 Jun; 14 Suppl 7():O31-5; discussion O41-2. PubMed ID: 15503374
    [No Abstract]   [Full Text] [Related]  

  • 9. MultiHance in liver lesion detection: personal experience.
    Grazioli L
    Eur Radiol; 2004 Jun; 14 Suppl 7():O25-30; discussion O41-2. PubMed ID: 15503373
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multicenter analysis of tolerance and clinical safety of the extracellular MR contrast agent gadobenate dimeglumine (MultiHance)].
    Herborn CU; Jäger-Booth I; Lodemann KP; Spinazzi A; Goyen M
    Rofo; 2009 Jul; 181(7):652-7. PubMed ID: 19291607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadobenate dimeglumine (Multihance) in magnetic resonance mammography.
    Kirchin MA; Salerio I; La Noce A
    Acad Radiol; 2002 Aug; 9 Suppl 2():S348-51. PubMed ID: 12188271
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials.
    Frank JA; Bash C; Stone L; Petrella J; Maloni H; McFarland H
    Acad Radiol; 1996 Aug; 3 Suppl 2():S173-5. PubMed ID: 8796554
    [No Abstract]   [Full Text] [Related]  

  • 13. High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors.
    Pinker K; Noebauer-Huhmann IM; Stavrou I; Hoeftberger R; Szomolanyi P; Weber M; Stadlbauer A; Grabner G; Knosp E; Trattnig S
    Neuroradiology; 2008 Jan; 50(1):9-16. PubMed ID: 17876570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a high relaxivity contrast agent administered at half dose in dynamic susceptibility contrast MRI of brain gliomas.
    Crisi G; Filice S; Erb G; Bozzetti F
    J Magn Reson Imaging; 2017 Feb; 45(2):500-506. PubMed ID: 27373976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings of the MultiHance (gadobenate dimeglumine) user group meeting. December 19-20, 2003. Rome, Italy.
    Eur Radiol; 2004 Jun; 14 Suppl 7():O1-88. PubMed ID: 15678593
    [No Abstract]   [Full Text] [Related]  

  • 16. MultiHance in the assessment of intracranial tumors: results of phase II clinical studies.
    Ruscalleda J; Kirchin MA; La Noce A; Pirovano G; Spinazzi A
    J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S19-27. PubMed ID: 10608394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR angiography with MultiHance for imaging the supra-aortic vessels.
    Catalano C; Pediconi F; Nardis P; Roselli A; Cavacece M; Bertoletti L; Passariello R
    Eur Radiol; 2004 Jun; 14 Suppl 7():O45-51; discussion O61-2. PubMed ID: 15503376
    [No Abstract]   [Full Text] [Related]  

  • 18. Diffusion-perfusion in intra-axial brain tumors with high relaxivity contrast agents.
    Cotton F
    Neuroradiology; 2006 Apr; 48 Suppl 1():34-40. PubMed ID: 16699850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with MultiHance in CNS imaging.
    Essig M
    Eur Radiol; 2003 Nov; 13 Suppl 3():N3-10. PubMed ID: 15015875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MultiHance in body MR angiography: personal experiences.
    Ahlström H
    Eur Radiol; 2004 Jun; 14 Suppl 7():O52-4; discussion O61-2. PubMed ID: 15503377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.